|
It is sometimes heard that the rabies vaccine is ineffective in wolves and wolf/dog crosses. Such claims are usually made by those who disapprove of wolfdogs as companion animals, or local government overreaching attempts to make private ownership illegal. While the canine rabies vaccine is not officially 'approved' for wolves and wolfdogs, it is in fact widely recognized to be effective in both wolves and wolf/dog crosses.
In 1993, taxonomists reclassified domestic dogs. Formerly known as Canis familiaris, domestic dogs are now considered to be simply a subspecies of wolf, Canis lupus. The reclassification was documented in 'Mammal Species of the World, A Taxonomic and Geographic Reference', which is recognized to be the standard for mammalian taxonomy.
Based upon the reclassification, the US Animal and Plant
Health Inspection Service (APHIS), which regulates vaccine protocol in all animals, was petitioned to recognize the rabies vaccine approved for dogs as being effective for both wolves and wolfdog crosses. A proposed rule to amend the Virus-Serum-Toxin Act regulation by adding a definition of the term 'dog' to include all members of the species Canis familiaris, Canis lupus, or any dog-wolf cross was attempted in September 1999. The following observations and conclusions regarding the efficacy of the rabies vaccine in wolfdogs were published by APHIS and documented in the proposed rule change, and be read in the Federal Register Volume 64, Number 187, Page 52247-52248, September 28, 1999. Highlights from the proposed rule change follow:
The following excerpt was provided by Faye E. Sorhage, the New Jersey State Public Health Veterinarian overseeing the New Jersey Rabies Control Program. In correspondence dated October 2009, with regard to local officials concerned about wolfdogs being kept by a resident in Hunterdon County, New Jersey, Dr. Sorhage replied:
While it is widely acknowledged the current
canine rabies vaccine is effective for dogs, wolves
and wolfdogs, the outdated APHIS definition of the term
"dog" does not include wolves or wolf-dog
crosses. Consequently wolfdogs in many areas of the
country are outlawed or euthanized due to the mistaken
belief they cannot be effectively vaccinated for rabies
(ignoring the fact veterinarians, zoos and wildlife
sanctuaries have been vaccinating these animals
for decades, with no incidence of rabies).
The following documents were provided by APHIS to Howling Woods Farm after we made a request under the "'Freedom of Information Act" in 2002. These testimonials and decision documents are from APHIS, State veterinarians
in New Jersey, Alabama & Oregon, 15 local veterinarians, academic
scientists, attorneys, wolf rescue organizations, individuals,
and a vaccine manufacturer, all of whom advocate the
effectiveness of the canine rabies vaccine for wolves
and wolfdogs. APHIS itself has acknowledged that while not approved 'on-label', the rabies vaccine is effective for wolves and wolfdogs.
These documents may prove useful to
anyone who owns wolfdog and is challenged by their veterinarian
or local animal control regarding the effectiveness
of the rabies vaccine. Also see additional information provided regarding APHIS vaccine development protocols and the APHIS rulemaking
processes.
Faye E. Sorhage, New Jersey State Public Health Veterinarian Oct 5, 2009
Donna M. Gatewood, DVM, MS, Section Leader, Virology, USDA/APHIS/VS/CVB
United
States Wolf Refuge, ArizonaAmerican
Animal Hospital Association, Colorado
Andrew
Clark, State Veterinarian, Oregon
William
Johnson, State Veterinarian, Alabama
Fort
Dodge Animal Health, Iowa
N.E.
Federoff, Wildlife Biologist, Virginia
Diane
Delbridge, DVM, Oklahoma
William
Ridenour, DVM, West Virginia
Lorri
Stewart, DVM, Michigan
Jan
Yerk, DVM, Indiana
K.
Patrick Rains, DVM, California
Jim
Cole, DVM, Elise Elliot, DVM, New Mexico
Dorothy
Prendergast, Wildlife Education and Research Foundation,
New Mexico
Dr.
Stephanie Porter, University of Colorado Health Sciences
Center, Colorado
I.
Lehr Brisbin, Senior Ecologist, University of Georgia,
Savannah River Ecology Laboratory, Georgia
Debbie
Thurman-Beznal, Texas
Martha
Eaton, DMV, California
Ronald
T. West, Attorney, Alaska
Jan
Noda, New Mexico
Michael
Siegle, Ph.D., New Mexico
Lynn
D. Andrade, MedCon LLC, Arizona
Ken
Podkonjak, DVM, New Mexico
The
Humane Society of the United States, Washington, DC
David
LaFever, DVM, Kentucky
Additional Information regarding
APHIS rule making procedures and vaccine development
protocols
The Proposed Rule (Federal Register: September 28, 1999 (Volume 64, Number 187)] Page 52247-52248)
The Proposed
Rule Withdrawal (Federal Register: April 18, 2001 (Volume 66, Number 75)] Page 19899-19990)l
Rule
Withdrawal Office Copy with Handwritten Notes
Rule
Withdrawal Worksheet
Rulemaking in APHIS an Overview
Rule
Development and Clearance Process
Virus-Serum-Toxin
Act
General
Licensing Considerations Efficacy Studies
Functions
Assigned to Regulatory Analysis and Development
113.209
Rabies Vaccine
Rabies
Vaccine Immunogenicity Test Protocols
Production
Outline for Vaccines, Bacterins, Antigens & Toxoids
Supplemental
Assay Method for Potency Testing
Alternative
Safety Testing - Oral Antibody Products
From: Donna.M.Gatewood@aphis.usda.gov
Sent: Thursday, June 10, 2010 10:02 AM
To: Xss@xxxxxxxxxx.com
Subject: Fw: Question from Ask the Expert-- Veterinary - 1275422414050
This query was forwarded to me for response in my capacity as the Section Leader for Virology at the USDA's Center for Veterinary Biologics (CVB). The CVB is the regulatory authority for licensing and labeling of veterinary vaccines, diagnostic kits, and other biological products.
The USDA approves label claims based on scientific data submitted by the regulated industry. Our regulations require that rabies products be shown to be effective in each species for which there is a label claim. No rabies vaccine manufacturers to date have conducted studies to support the use of rabies products in wolves or wolf-dog hybrids.
In those states which have specific legislation declaring wolf-dog hybrids to be the same species as domestic dogs, the use of rabies vaccines in wolf-dog hybrids would be considered to be in accordance with the label claims if the product is licensed for use in dogs. However, some states consider dogs and wolves to be distinct species, and consider the use of rabies vaccines in wolves and wolf-dog hybrids to be "off-label" use. Depending upon state and local statutes, such animals may be considered to be unvaccinated in the event that the animal bites 1) bites a human or 2) is exposed to a rabid or suspected-rabid animal. The USDA does not have jurisdiction over such matters.
Part of the reason behind state differences is the fact that there is general disagreement among taxonomists with regard to the taxonomic classification of wolves and dogs. Some taxonomy experts consider domestic dogs to be a subspecies of wolves, while others consider them to be distinct species within the same genus. Again, the USDA does not have jurisdiction over such matters.
Please feel free to contact me if you have further questions.
Sincerely,
Donna M. Gatewood, DVM, MS
Section Leader, Virology
Policy, Evaluation, and Licensing
USDA/APHIS/VS/CVB
1920 Dayton Avenue
Ames, IA 50010
(515) 337-6150
Mail Stop: 2N005
|